LANGHORNE, Pa., May 13, 2025–Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the first quarter ending March 31, 2025 and provided a business update.Read More
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update
